This grant, issued by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), is for the purpose of advancing translational research in pediatric and obstetric pharmacology. It aims to improve existing drug safety and efficacy, and facilitate the development of new drugs specifically for children and pregnant women. Key objectives include conducting pharmacological studies that address the unique differences in drug actions and responses across various developmental stages in children, between children and adults, and between pregnant and non-pregnant women. The funding also supports the development of novel therapeutic agents for these populations and fosters multidisciplinary collaborations between basic and physician scientists to optimize therapeutic practices in obstetrics and pediatrics. This initiative utilizes the NIH Research Project Grant (R01) mechanism to drive significant advancements in these critical areas of public health.
Opportunity ID: 46728
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | PAR-09-155 |
| Funding Opportunity Title: | Translational Research in Pediatric and Obstetric Pharmacology (R01) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Health Income Security and Social Services |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.865 — Child Health and Human Development Extramural Research |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Apr 10, 2009 |
| Last Updated Date: | – |
| Original Closing Date for Applications: | May 19, 2011 |
| Current Closing Date for Applications: | May 19, 2011 |
| Archive Date: | Jun 19, 2011 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education State governments County governments Private institutions of higher education Special district governments Public housing authorities/Indian housing authorities Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Small businesses Others (see text field entitled “Additional Information on Eligibility” for clarification) City or township governments Public and State controlled institutions of higher education Native American tribal organizations (other than Federally recognized tribal governments) Independent school districts Native American tribal governments (Federally recognized) For profit organizations other than small businesses |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | Purpose. This funding opportunity announcement (FOA) issued by the Eunice Kennedy Shriver National Institute of Child Health and Human Development encourages research grant applications to conduct studies to improve existing drug saftey and efficacy, and to develop new drugs for pediatric and obstetric populations. The overall goals of this FOA are to support: (1) pharmacological studies addressing the special differences of drug actions and responses among children at various developmental stages, between children and adults, and between pregnant and non-pregnant women; (2) development of new drug targeting children and pregnant women; (3) multidisciplinary collaborations between basic and physician scientists to improve the use of therapeutics in obstetrics and pediatrics. Mechanism of Support. This FOA will utilize the NIH Research Project Grant (R01) mechanism and runs in parallel with FOAs of identical scientific scope, PAR-09-154 that encourages applications under the R03 grant mechanism and PAR-09-156 that encourages applications under the R21 grant mechanism. Funds Available and Anticipated Number of Awards. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/pa-files/PAR-09-155.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
There are no related documents on this grant.
Packages
| Agency Contact Information: | NIH OER Webmaster FBOWebmaster@OD.NIH.GOV Email: FBOWebmaster@OD.NIH.GOV |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| 93.865 | ADOBE-FORMS-B | Use for submissions intended for due dates of January 25, 2010 and beyond | PKG00016139 | Jan 30, 2010 | Oct 19, 2010 | View |
| 93.865 | ADOBE-FORMS-A | Adobe-Forms-A | PKG00011581 | Aug 16, 2009 | Jan 30, 2010 | View |
| 93.865 | ADOBE-FORMS-B1 | Supersedes ADOBE-FORMS-B | PKG00021973 | Oct 19, 2010 | May 19, 2011 | View |
Package 1
Mandatory forms
46728 RR_SF424_1_2-1.2.pdf
46728 PerformanceSite_1_3-1.3.pdf
46728 RR_OtherProjectInfo_1_2-1.2.pdf
46728 RR_KeyPersonExpanded_1_2-1.2.pdf
46728 PHS398_CoverPageSupplement_1_4-1.4.pdf
46728 PHS398_ResearchPlan_1_3-1.3.pdf
46728 PHS398_Checklist_1_3-1.3.pdf
Optional forms
46728 PHS_CoverLetter_1_2-1.2.pdf
46728 PHS398_ModularBudget-1.1.pdf
46728 RR_Budget-1.1.pdf
46728 RR_SubawardBudget-1.2.pdf
Package 2
Mandatory forms
46728 RR_SF424-1.1.pdf
46728 RR_KeyPersonExpanded-1.1.pdf
46728 RR_OtherProjectInfo-1.1.pdf
46728 RR_PerformanceSite-1.1.pdf
46728 PHS398_CoverPageSupplement-1.1.pdf
46728 PHS398_ResearchPlan-1.1.pdf
46728 PHS398_Checklist-1.1.pdf
Optional forms
46728 PHS398_CoverLetter-1.1.pdf
46728 PHS398_ModularBudget-1.1.pdf
46728 RR_Budget-1.1.pdf
46728 RR_SubawardBudget-1.2.pdf
Package 3
Mandatory forms
46728 RR_SF424_1_2-1.2.pdf
46728 RR_OtherProjectInfo_1_3-1.3.pdf
46728 RR_KeyPersonExpanded_1_2-1.2.pdf
46728 PerformanceSite_1_4-1.4.pdf
46728 PHS398_ResearchPlan_1_3-1.3.pdf
46728 PHS398_CoverPageSupplement_1_4-1.4.pdf
46728 PHS398_Checklist_1_3-1.3.pdf
Optional forms
46728 RR_Budget-1.1.pdf
46728 RR_SubawardBudget-1.2.pdf
46728 PHS_CoverLetter_1_2-1.2.pdf
46728 PHS398_ModularBudget-1.1.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
